switch helix changes solvent accessibility of Thr-171 and Leu-174 that affects the domain interface. Although the Ca 2؉ switch helix is not part of the RetGC1 binding site, insertion of an extra Gly residue between Ser-173 and Leu-174 as well as deletion of Arg-172, Ser-173, or Leu-174 all caused a decrease in Ca 2؉ binding affinity and abolished RetGC1 activation. We conclude that Ca 2؉ -dependent conformational changes in the Ca 2؉ switch helix are important for activating RetGC1 and provide further support for a Ca 2؉ -myristoyl tug mechanism.
Guanylyl cyclase activating proteins (GCAPs) 2 belong to the neuronal calcium sensor (NCS) branch of the calmodulin superfamily (1-3) and regulate Ca 2ϩ -sensitive activity of retinal guanylyl cyclase (RetGC) in rod and cone cells (4 -6) . Phototransduction in retinal rods and cones is modulated by intracellular Ca 2ϩ sensed by GCAPs (7, 8) , and defects in Ca 2ϩ signaling by GCAPs are linked to retinal diseases (9) . GCAP proteins in the Ca 2ϩ -free/Mg 2ϩ -bound state activate RetGC (10), whereas Ca 2ϩ -bound GCAPs inhibit RetGC at high Ca 2ϩ levels maintained in the dark (11) (12) (13) .
The GCAPs (GCAP1 (6), GCAP2 (14) , GCAP3 (15) , and GCAP4 -8 (16) are all ϳ200-amino acid residue proteins containing a covalently attached N-terminal myristoyl group and four EF-hand motifs (EF1 through EF4; Fig. 1 ). Mg 2ϩ binds to GCAP1 in place of Ca 2ϩ when cytosolic Ca 2ϩ levels are below 50 nM in light-activated photoreceptor cells (17) . This Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 is called the activator form because it activates RetGC (10, 18, 19) . The x-ray crystal structure of Ca 2ϩ -bound GCAP1 (20) and NMR structure of GCAP2 (21) showed that the four EF-hands form two semiglobular domains (EF1 and EF2 in the N-domain and EF3 and EF4 in the C-domain); Ca 2ϩ is bound at EF2, EF3, and EF4, and the N-terminal myristoyl group in GCAP1 is buried inside the Ca 2ϩ -bound protein flanked by hydrophobic residues at the N and C termini (see the red residues in Fig. 1 ). The structure of the physiological activator form of GCAPs (Mg 2ϩ -bound/Ca 2ϩ -free state) is currently unknown.
The structure of the Ca 2ϩ -free/Mg 2ϩ -bound activator state of GCAP1 has remained elusive, in part because it tends to aggregate under conditions for NMR or x-ray crystallography (22) . Here, we present a NMR structural analysis of Ca 2ϩ -free/ Mg 2ϩ -bound GCAP1 mutant that has Val-77 replaced by Glu (called GCAP1 V77E ). The GCAP1 V77E mutant retains functional Mg 2ϩ and Ca 2ϩ binding with intact tertiary structure. However, unlike the dimeric wild type GCAP1, GCAP1 V77E is monomeric in solution and remains soluble under NMR conditions. Our NMR analysis indicates that Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 V77E is overall structurally similar to that of Ca 2ϩ -saturated GCAP1 (root mean square deviations of 2.0 Å), except that Mg 2ϩ is bound at EF2, and the other EF-hands are unoccupied. The largest Ca 2ϩ -dependent structural differences in GCAP1 are seen for residues in EF4 and the adjacent helical region (residues 164 -174, called Ca 2ϩ switch helix). We propose that the Ca 2ϩ switch helix may serve as a conduit that relays Ca 2ϩ -induced structural changes in EF4 to the RetGC binding site in the N-terminal domain, which provides further support of a Ca 2ϩ -myristoyl tug mechanism (23) .
Experimental Procedures
Expression and Purification of GCAP1 and Mutants-Mutations were introduced in a bovine GCAP1 coding plasmid using a "splice by overlap extension" approach as previously described (24) . Myristoylated GCAP1 and its mutants were produced in Escherichia coli strain harboring yeast N-myristoyl * This work was supported by National Institutes of Health Grants EY012347 (to J. B. A.), EY11522 (to A. M. D.), and RR11973 (UC Davis NMR). This work was also supported by a Pennsylvania Department of Health CURE Formula grant (to A. M. D.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. transferase and purified to homogeneity using a previously described method (10) . The expression and purification of isotopically labeled GCAP1 and mutants were described previously (22, 25 Mutagenesis-Mutations were introduced in bovine GCAP1 cDNA by "splicing by overlap extension" technique using PCR reactions catalyzed by high-fidelity Phusion Flash polymerase (Finnzymes/Thermo Scientific). The resultant products were ligated into the NcoI/BamHI sites of pET11d (Novagen/Calbiochem) vector, sequenced, and transformed into expressing cell lines as described previously in detail (19) .
Trp Fluorescence Spectroscopy-The intrinsic Trp fluorescence of GCAP1 and its mutants was recorded in the presence of variable-free Mg 2ϩ and Ca 2ϩ concentrations as previously described in detail (19, 23) .
Ca 2ϩ Binding Stoichiometry-The stoichiometry of Ca 2ϩ binding to myristoylated and non-acylated GCAP1 and its mutants was determined using the fluorescent Ca 2ϩ indicator dye method previously described in detail (19, 23) using Fluo-4FF (Molecular Probes/Fisher). Free Ca 2ϩ in the reaction mixture was calculated using the formula [Ca] /ethylene glycol tetraacetic acid (EGTA) buffers for the assay were prepared and calibrated as previously described (10) .
NMR Spectroscopy-Samples for NMR analyses were prepared by dissolving unlabeled, 15 N-labeled, 13 C, 15 N-labeled, or 13 was generated based on NMR data (chemical shifts, residual dipolar couplings (RDCs) and NOEs) using the Xplor-NIH software suite (29, 30). A template structure for the model calculation was first built using SWISS-MODEL based on the x-ray crystal structure of Ca 2ϩ -bound GCAP1 (PDB ID 2R2I). The N-terminal myristoyl group was attached to the template structure as it is in the crystal structure (PDB ID 2R2I). The three Ca 2ϩ ions were deleted, and a single Mg 2ϩ ion was added to the second EF-hand metal binding loop as described by Park et al. (31) . The template structure of Mg 2ϩ -bound GCAP1 V77E then served as input for restrained molecular dynamics (32) followed by refinement (using refine.py) within the Xplor-NIH software suite (30). RDC and NMR restraints (NOEs and dihedral angles) were applied during the simulated annealing step. Dihedral angles were calculated by the Talosϩ program (33). For under-assigned secondary structural motifs, theoretical restraints within the initial template structure were used to supplement the experimental restraints. Refinement of the final structure was initiated with high temperature annealing at 1000 K for 10 ps, and cooling from 1000 K to 25 K in 12.5 K steps. The duration of cooling dynamics run at each step was 0.2 ps. A total of 500 structures were obtained, and the 75 lowest energy structures were chosen to generate an energy-minimized average structure. The structural statistics are shown in Table 1 .
Isothermal Titration Calorimetry-ITC experiments were performed using a VP-ITC calorimeter (Micro-Cal) at 30°C, and data were acquired and processed with MicroCal software as described previously (34). Metal-free GCAP1 V77E samples were prepared by exchanging protein into buffer containing 15 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 1 mM ␤-mercaptoethanol. The metal-free GCAP1 V77E in the sample cell (50 M, 1.5 ml) was titrated with either Ca 2ϩ (2 mM) or Mg 2ϩ (40 mM) using 40 injections of 5 l each. forms a monomer in solution under NMR conditions (22) , in contrast to Ca 2ϩ -free/Mg 2ϩ -bound wild type GCAP1 that tends to aggregate and/or form dimers under NMR conditions (22) . The relative peak positions and spectral patterns overall look similar when comparing spectra of wild type (Fig. 3A) to that of GCAP1 V77E (Fig. 3B) , indicating that Mg 2ϩ -bound/ Ca 2ϩ -free GCAP1 V77E retains the same main chain fold compared with wild type. The monomeric state of GCAP1 V77E caused much sharper NMR line width s compared with that of dimeric wild type (Fig. 3, A versus B) . The sharper NMR peaks observed for Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 V77E allowed ϳ60% assignment of backbone resonances compared with Ͻ25% assignment for Ca 2ϩ -free wild type and ϳ80% assignment for Ca 2ϩ -saturated GCAP1 (37) . The unassigned residues for GCAP1 V77E included the first 20 residues from the N terminus and unstructured regions (Lys-46 -Trp-51, Met-74 -Asp-108, Ile-119 -Met-129, Asp-143-Leu-150, Arg-177-Gln-183). These unassigned residues have weak NMR intensities due to exchange broadening, suggesting that these residues undergo dynamical motions on the chemical shift time scale. The exchange broadening of residues at the domain interface in Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 (residues Lys-91-Tyr-99) is similar to that seen in Ca 2ϩ -free recoverin (38, 39) . Downfield-shifted NMR peaks at ϳ10.5 ppm for GCAP1 V77E are assigned to conserved glycine residues in the EF-hand Ca 2ϩ binding loops and are characteristic of Ca 2ϩ /Mg 2ϩ -bound EFhands. In Ca 2ϩ -saturated GCAP1 V77E (Fig. 3C) , three downfield peaks assigned to Gly-69 (EF2), Gly-105 (EF3), and Gly-149 (EF4) confirm that Ca 2ϩ is bound at EF2, EF3, and EF4 as seen in the crystal structure (20) . In Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 V77E (Fig. 3B) , one downfield peak assigned to Gly-69 (EF3) confirmed that Mg 2ϩ is bound at EF2 as seen by fluorescence spectroscopy (10, 19) .
Results
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-free/Mg 2ϩ -bound GCAP1 V77E -The sequence-specific NMR assignments above for Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 V77E and the secondary structure based on these assignments is summarized in Fig. 1 . An NMR-derived structural model of Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 V77E was calculated using NOE-based distances, NMRderived dihedral angle restraints, and RDC data (Fig. 4) that served as input for restrained molecular dynamics structure calculations (see "Experimental Procedures"). Initial residual dipolar coupling magnitude and rhombicity were calculated by fitting the measured residual dipolar couplings to the calculated structure using the PALES program (40) . The RDC-refined structures have a quality Q-factor of 0.28 and an R-factor of 0.995 (Fig. 4C) . The overall secondary structure and topology of Mg 2ϩ -bound GCAP1 V77E is similar to that found in the crystal structure of Ca 2ϩ -bound GCAP1 (20) . The NMR-derived V77E contains two separate domains comprising four EF hands: EF1 (green, residues 18 -43) and EF2 (red, residues 51-83) form the N-terminal domain; EF3 (cyan, residues 90 -119) and EF4 (yellow, residues 132-161) form the C-terminal domain. Two C-terminal helices are downstream of EF4 (␣10 and ␣11 in Fig.  4) . The helix immediately adjacent to EF4 (␣10, highlighted in orange in Fig. 5B ) is one-half turn longer in Ca 2ϩ -free/Mg 2ϩ -bound GCAP1
V77E compared with that of Ca 2ϩ -bound GCAP1 (Fig. 6 ). The C-terminal helix (␣11) has the same length in both Ca 2ϩ -free and Ca 2ϩ -bound GCAP1 and makes contacts with the N-terminal myristoyl group (Fig. 5) . GCAP1 V77E contains Mg 2ϩ bound at EF2 (blue sphere in Fig.  5 ) as evidenced by characteristic Mg 2ϩ -dependent amide chemical shift changes assigned to Gly-69 in EF2 ( Fig. 2A, inset) . The geometry of the coordinate covalent bonds formed between chelating amino acid residues in GCAP1 V77E and the bound Mg 2ϩ could not be observed directly in our NMR study. Instead, the stereochemical geometry and chelation of Mg 2ϩ bound at EF2 was modeled with structural constraints derived from the x-ray crystal structure of Mg 2ϩ -bound CaM (41), which closely resembles the Mg 2ϩ binding site geometry conserved in other EF-hand proteins such as CaBP1 (35) and CaBP4 (31). GCAP1 residues at the 1, 3, and 5 positions of the EF-hand loop in EF2 were selected to chelate the bound Mg 2ϩ (see D64 and D68 in Fig. 5A ). Replacement of these two residues disrupted Mg 2ϩ binding in our previous biochemical studies (19) .
The four EF-hands of GCAP1 V77E with one Mg 2ϩ bound at EF2 (and no metal bound at EF1, EF3, and EF4) each adopt interhelical angles that are similar to those observed in the crystal structure of Ca 2ϩ -bound GCAP1 ( GCAP1 cause only a slight change in interhelical angle. In essence, the three functional EF-hands in GCAP1 adopt a "pre-formed" open conformation in the Ca 2ϩ -free state akin to that of calbindin D 9k (42) and other Ca 2ϩ buffer proteins (43) . As a result, the Ca 2ϩ -binding free energy for GCAP1 is NOT coupled to an unfavorable conformational change, which may explain the very high nanomolar Ca 2ϩ binding affinity for GCAP1 (25). By stark contrast, myristoylated recoverin (that undergoes a Ca 2ϩ -myristoyl switch (44) ) and CaM (that undergoes an open-to-closed transition (43)) both bind Ca 2ϩ with ϳ100-fold lower affinity compared with myristoylated GCAP1 (25).
Ca
2ϩ -induced Conformational Changes in GCAP1-Chemical shift differences in GCAP1 versus Ca 2ϩ were plotted as a function of residue number and reveal the location of Ca 2ϩ -dependent structural changes (Fig. 6A) . Detectable chemical shift differences are seen for residues in EF1 (residues 26, 27, and 33) that are implicated in RetGC1 binding (36) . Somewhat larger chemical shift changes are seen in EF2 (residues 55, 62, and 68), which represent residues at the domain interface and suggest Ca 2ϩ -dependent structural contacts between EF2 and EF3 like that seen previously for recoverin (38, 45) . The largest chemical shift differences (highlighted in red in Fig. 6B ) are observed in EF4 (residues 140, 151-152, and 160) and helix ␣10 (residues (Fig. 6C ) reveals two residues (Thr-171 and Leu-174) that are most affected by Ca 2ϩ . Thr-171 is exposed in the Ca 2ϩ -free structure, whereas it becomes buried and makes contact with Leu-92 in the Ca 2ϩ -bound structure. Conversely, Leu-174 is buried and makes contact with Leu-92 in the Ca 2ϩ -free structure, but it switches to a solvent-exposed environment in the Ca 2ϩ -bound structure. The Ca 2ϩ -dependent contacts formed by both Thr-171 and Leu-174 may be important for switching GCAP1 from the Ca 2ϩ -free activator to the Ca 2ϩ -bound inhibitor states.
Mutations in the Ca 2ϩ Switch Helix Affect Metal Binding and Cyclase Activation-The calcium-myristoyl tug hypothesis (23) proposes a structural link between the exiting helix of EF4 and residues that contact the myristoyl group in the N-domain. Ca 2ϩ -induced structural changes in EF4 exert a "tug" on downstream C-terminal residues that are in contact with the myristoyl group. These Ca 2ϩ -dependent contacts to the myristate are then relayed to the target binding site in the N-domain (36) . We hypothesized that the Ca 2ϩ -induced shortening of the Ca 2ϩ switch helix observed in our structure (Fig. 6 ) may transmit the tug action that connects Ca 2ϩ binding at EF4 with target activation in the N-domain. Therefore, we tested if a change in the length of the Ca 2ϩ switch helix by mutagenesis could affect the regulatory properties of GCAP1. We constructed a series of mutants in which the length of the helix was altered either by insertion or deletion of a single amino acid: a Gly was inserted between Ser-173 and Leu-174 (SGL mutant, Fig. 7) , and single amino acids were deleted: Arg-172 (⌬Arg-172), Ser-173 (⌬Ser-173), or Leu-174 (⌬Leu-174) (Fig. 8) . NMR HSQC spectra demonstrate that these mutations do not alter the conformation of ␣10 and these mutants are structurally intact (Fig.  3D) . We found that each of these mutants (which changes the length of the Ca 2ϩ switch helix) profoundly affected both the metal binding affinity of GCAP1 and its ability to activate RetGC. The Ca 2ϩ binding stoichiometry in the SGL mutant remained three per GCAP1 molecule, but the apparent affinity decreased slightly with higher cooperativity compared with that of wild type (Fig. 6A) . Metal-dependent changes in the intrinsic Trp fluorescence of the SGL mutant looked quite different from that of wild type (Fig. 7, B-D) . The Ca 2ϩ -induced decrease in fluorescence (in the absence of Mg 2ϩ ) occurred at higher Ca 2ϩ levels in SGL compared with wild type (Fig. 7B) . The presence of 10 mM Mg 2ϩ (that normally causes a quite striking Ca 2ϩ -induced increase in Trp fluorescence for wild type) resulted in much smaller Ca 2ϩ -dependent change in Trp fluorescence for SGL (Fig. 7C) . Thus, the transition from the Mg 2ϩ -bound activator state to the Ca 2ϩ -bound inhibitor state in the presence of 10 mM Mg 2ϩ (19) was more difficult to mon- 
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itor in SGL compared with wild type (Fig. 7C) . In addition, the Trp fluorescence of the SGL mutant titrated as a function of Mg 2ϩ revealed a nearly 10-fold lower Mg 2ϩ binding affinity compared with that of wild type (Fig. 7D) . Because Mg 2ϩ binding to EF2 is essential for converting GCAP1 into its activated state in the absence of Ca 2ϩ (10, 19) , we tested if RetGC1 activation was also affected by this mutation. Indeed, the SGL mutant failed to activate RetGC1 at physiological concentrations of Mg 2ϩ and when the Ca 2ϩ concentration was reduced to levels typical of light-exposed photoreceptors (Fig. 7D) .
Making the Ca 2ϩ switch helix shorter by a single residue produced a similar effect regardless of which amino acid was deleted, Arg-172, Ser-173, or Leu-174 (Fig. 8) . In all three deletion mutants, the Ca 2ϩ -induced decrease in Trp fluorescence looked similar to that of wild type (Fig. 8, A-C, red symbols) , except for a slight 2-fold shift toward higher Ca 2ϩ concentrations (Fig. 8D ). As seen above for SGL, the presence of 10 mM Mg 2ϩ caused a much smaller change in Ca 2ϩ -dependent Trp fluorescence for each of the deletion mutants, thus making it difficult to monitor the transition from the Mg 2ϩ -bound activator state to the Ca 2ϩ -bound inhibitor state (Fig. 8 , A-C, blue symbols) in contrast to the much larger Ca 2ϩ -induced fluorescence change seen for wild type (Fig. 7B ). As seen above for SGL, the Trp fluorescence of the deletion mutants titrated as a function of Mg 2ϩ revealed a nearly 10-fold lower Mg 2ϩ binding affinity compared with that of wild type (Fig. 8E) . Finally, the deletion mutants all failed to activate RetGC1 at physiological concentrations of Mg 2ϩ , consistent with their lack of Mg 2ϩ binding (Fig. 8F ).
Discussion
NCS proteins like recoverin and NCS-1 undergo large Ca 2ϩ -induced conformational changes that cause extrusion of the N-terminal myristoyl group, termed Ca 2ϩ -myristoyl switch (38, 46 -48) . Surprisingly, the GCAP proteins do not possess a Ca 2ϩ -myristoyl switch (17, 49, 50) , and the N-terminal myristoyl group remains buried inside the protein in both Ca 2ϩ -free and Ca 2ϩ -bound GCAPs (17, 51) . Although NMR and crystal structures are known for Ca 2ϩ -bound GCAPs (20 -22, 52), before this study little was known structurally about the Mg 2ϩ -bound/Ca 2ϩ -free activator state of GCAPs and how Ca 2ϩ -induced conformational changes in GCAPs control cyclase activation.
In this study we present NMR assignments (Fig. 3B) , NOEs (Table 1) , RDCs (Fig. 4) , and mutagenesis data (Fig. 7) to probe Ca 2ϩ -dependent conformational changes between the Ca 2ϩ -saturated inhibitory state versus the Ca 2ϩ -free/Mg 2ϩ -bound GCAP1 V77E (Fig. 6) . Overall, the NMR chemical shift differences between Ca 2ϩ -saturated wild type GCAP1 and Ca 2ϩ -free/Mg 2ϩ -boundGCAP1 V77E arerelativelysmall (Fig.6A) ,consistent with an overall similar main chain conformation for the two states (root mean square deviations ϭ 2.0 Å). This contrasts with the large Ca 2ϩ -induced conformational changes seen for other EF-hand proteins, including recoverin (38), NCS-1 (48), CaM (53, 54) , and troponin-C (55) . The large Ca 2ϩ -induced conformational changes in recoverin and CaM both drive the exposure of hydrophobic residues, which consumes Ca 2ϩ binding free energy and accounts for their low binding affinity. The Ca 2ϩ -free EF-hands in GCAP1 adopt a preformed open conformation, like what is seen for calbindin D9k (42) and other Ca 2ϩ buffer proteins (43) . The lack of any large scale Ca 2ϩ -induced protein conformational change in GCAP1, therefore, may explain why the GCAPs bind Ca 2ϩ with at least 100-fold higher affinity compared with that of recoverin (44) and CaM.
The most apparent Ca 2ϩ -induced structural changes in GCAP1 are localized in EF4 and the adjacent Ca 2ϩ switch helix (␣10). Ca 2ϩ binding to EF4 is essential for switching GCAP1 between activator and inhibitor states (10, 19) . Upon Ca 2ϩ binding to EF4, its interhelical angle decreases by 2° (Table 2) along with a slight lengthening of the exiting helix (␣9) that in turn exerts a force (tug) on the adjacent Ca 2ϩ switch helix (␣10). As a result, the Ca 2ϩ switch helix is one half-turn longer in the Ca 2ϩ -free structure compared with the Ca 2ϩ -bound structure (Fig. 6, B and C) . The Ca 2ϩ -induced shortening of the Ca 2ϩ switch helix alters the disposition of key residues (Thr-171 and Leu-174) that form Ca 2ϩ -dependent contacts with EF3 (Leu-92 and Tyr-95). These Ca 2ϩ -dependent contacts alter the packing angle between helices ␣5 and ␣6 at the domain interface (Fig. 6C ) that resembles the Ca 2ϩ -induced domain swiveling in recoverin (38) . The Ca 2ϩ -dependent structural changes in the Ca 2ϩ switch helix also exert a force on the C-terminal helix (␣11) that alters its contact with the myristoyl group. We propose that this Ca 2ϩ -dependent perturbation of the myristoyl group could alter its contact with EF1 and EF2 and thereby affect the accessibility of GCAP1 residues (Met-26, Tyr-37, Val-77, and Ala-78) in the RetGC1 binding site (36) . In essence, the Ca 2ϩ -induced structural changes in EF4 are relayed to the cyclase binding site via the Ca 2ϩ switch helix. This relay scheme is consistent with a previously proposed mechanism called the Ca 2ϩ -myristoyl tug (23) . We further find here that even though the Ca 2ϩ switch helix (␣10) is not an immediate part of the RetGC binding interface (36) , the length of ␣10 critically affects proper binding of Ca 2ϩ (23) levels that occur in light-adapted photoreceptors (19, 36, 56) . Evidently, the length of the Ca 2ϩ switch helix (␣10) in wild type GCAP1 has evolved to optimize the proper tug action between the N-and C-domains, which tunes the Ca 2ϩ and especially Mg 2ϩ binding affinity into the physiological range. GCAP1 residues in EF2 and EF3 located at the domain interface (Val-77-Trp-94, see Figs. 1 and 6) exhibit exchange-broadened NMR resonances and are conformationally dynamic. The dynamical nature of these residues is consistent with Ca 2ϩ -induced conformational changes in GCAP1 at the domain interface that were observed previously (13, 57) . The corresponding residues in recoverin ( Fig. 1 ) also exhibited broad NMR resonances, and 15 N NMR relaxation dispersion studies revealed that these residues at the domain interface exhibit backbone dynamics on the millisecond timescale (45) . Ca 2ϩ -induced rearrangement of residues at the domain interface in recoverin gives rise to a 45-degree swiveling of the two domains (38 -induced rearrangement at the domain interface (Fig. 6) . Residues Tyr-55, Thr-62, and Ala-118 at the domain interface exhibit large Ca 2ϩ -induced chemical shift differences (Fig. 6A ). In addition, residues in EF3 (Leu-92 and Tyr-95) make Ca 2ϩ -dependent contacts with Thr-171 and Leu-174 in the Ca 2ϩ switch helix (Fig. 6C) . These Ca 2ϩ -dependent contacts to EF3 cause a change in packing angle between EF2 and EF3 at the domain interface (see the dotted line in Fig. 6C ) that is somewhat reminiscent of the Ca 2ϩ -dependent domain swiveling observed for recoverin (38, 45) .
NMR relaxation data and size-exclusion chromatography analysis previously showed that GCAP1 is dimeric in solution at high micromolar protein concentration (22) . A GCAP1 homolog, GCAP2, undergoes a Ca 2ϩ -sensitive dimerization at low -bound GCAP1 micromolar protein concentrations, which originally suggested that reversible dimerization may control formation and activation of RetGC:GCAP in a 2:2 complex (58, 59). Although dimerization of GCAP1 observed by Lim et al. (22) does not appear to be Ca 2ϩ -sensitive, it is possible that GCAP1 dimerization might promote a functional interaction within a RetGC1 dimer on the disk membrane (60, 61) . The binding stoichiometry of the GCAP1:RetGC1 complex has been estimated to be equimolar (62), consistent with a 2:2 complex that contains a RetGC1 dimer bound to a GCAP1 dimer. Previously we showed that the V77E mutation in GCAP1 eliminated GCAP1 dimerization and abolished its ability to bind RetGC but did not block its ability to undergo the functional transition between Ca 2ϩ -bound and Mg 2ϩ -bound states (22, 36) . If GCAP1 dimerization is important for RetGC activation, allosteric changes in the GCAP1 dimer quaternary structure may control cyclase activation. In this scenario a small Ca 2ϩ -induced change in tertiary structure could lead to a much larger change in quaternary structure akin to the O 2 -dependent conformational changes in hemoglobin (63) . Hydrophobic residues at the GCAP1 domain interface (Val-77, Ala-78, Leu-82, Trp-94) are solvent-exposed and might mediate specific contacts that control RetGC1 binding and GCAP1 dimerization alike. However, it cannot be excluded that these exposed GCAP1 res- 
